Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
07/1998
07/16/1998WO1998030240A1 Treatment of lupus nephritis with anti-cd40l compounds
07/16/1998WO1998030239A2 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure
07/16/1998WO1998030227A1 Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
07/16/1998WO1998030224A1 Inhibitor of immunoglobulin e antibody production
07/16/1998WO1998030223A1 Cytokine related treatments of disease
07/16/1998WO1998030218A1 Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents
07/16/1998CA2278158A1 Cytokine related treatments of disease
07/16/1998CA2277910A1 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
07/16/1998CA2277582A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
07/16/1998CA2277223A1 Methods of therapeutic administration of anti-cd40l compounds
07/16/1998CA2277222A1 Treatment of lupus nephritis with anti-cd40l compounds
07/16/1998CA2276525A1 Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents
07/16/1998CA2276088A1 Secreted proteins and polynucleotides encoding them
07/16/1998CA2276085A1 Secreted proteins and polynucleotides encoding them
07/16/1998CA2276063A1 Secreted proteins and polynucleotides encoding them
07/16/1998CA2274731A1 Myelopeptides and their therapeutic use
07/15/1998EP0853125A2 cDNA clone HNFJD15 that encodes a human 7-transmembrane receptor
07/15/1998EP0853083A1 Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof
07/15/1998EP0852618A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
07/15/1998EP0852587A2 Synthetic peptides that inhibit il-6 activity
07/15/1998EP0852501A1 Use of hyaluronic acid as an immunosuppressant
07/15/1998EP0528926B1 Soluble peptide analogues containing binding sites
07/15/1998EP0497883B1 Compositions and their use for promoting immunopotentiation
07/15/1998CN1187821A Rapamycin derivatives
07/15/1998CN1187772A Method of preventing or treating allergies
07/15/1998CN1187769A Lactacystin analogs
07/15/1998CN1187490A 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
07/15/1998CN1187368A Recombinant coccidiosis vaccines
07/14/1998US5780667 Phosphodiesterase-4 and tumor necrosis factor inhibitor
07/14/1998US5780642 Imidazole derivatives as therapeutic agents
07/14/1998US5780592 Transplant, antitumor
07/14/1998US5780513 Administering aminoguanidine as nitric oxide synthase inhibitor
07/14/1998US5780508 Pharmacological preparations comprising a cystine derivative
07/14/1998US5780468 Heterocyclic derivatives, process for their preparation and their therapeutic use
07/14/1998US5780462 Methoxypoly(ethylene glycol) esters of rapamycin
07/14/1998US5780454 Boronic ester and acid compounds
07/14/1998US5780424 Purified ribosomal fractions separated from the nonphotosynthetic filamentous bacteria beggiatoales
07/14/1998US5780243 Methods for the quantitative analysis of organic compounds
07/14/1998US5780037 Determining the relative concentration of calcium-dependent sugar-binding proteins in an aqueous extract with respect to the total protein concentration to identify pharmaceutical grade products; aids; anticarcinogenic agents
07/14/1998US5780026 Immunomodulating and antiinflammatory agent
07/14/1998US5780025 Compositions and methods for the synthesis and assay of enkephalinase
07/14/1998US5780014 Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
07/14/1998CA1339954C Dogs - and horse - interferones
07/09/1998WO1998029452A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use
07/09/1998WO1998029430A1 G-rich oligo aptamers and methods of modulating an immune response
07/09/1998WO1998029124A1 Oligonucleotide compositions and methods for the modulation of the expression of b7 protein
07/09/1998WO1998029121A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent
07/09/1998WO1998021232A3 Mutant forms of fas ligand and uses thereof
07/09/1998CA2278031A1 G-rich oligo aptamers and methods of modulating an immune response
07/09/1998CA2276450A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent
07/08/1998EP0851927A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
07/08/1998EP0851925A1 Human growth hormone variants
07/08/1998EP0851875A2 Dna sequences and secreted proteins encoded thereby
07/08/1998EP0851873A2 Parainfluenza virus glycoproteins and vaccines
07/08/1998EP0851769A1 Gene therapy using ovine adenoviral vectors
07/08/1998EP0851759A1 Compounds and methods
07/08/1998EP0851753A1 Aerosol compositions
07/08/1998EP0820283A4 Lactacystin analogs
07/08/1998CN1187188A Small molecule inhibitors of rotamase enzyme activity
07/08/1998CN1187125A Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
07/08/1998CN1186695A Recombinant coccidiosis vaccines
07/08/1998CN1186684A Health medicine for tonifying kidney and its production process
07/08/1998CN1039012C Novel phospholipid derivatives
07/07/1998US5777193 Animals with targeted gene disruption
07/07/1998US5777176 4,4-(disubstituted)cyclohexan-1-ol dimers and related compounds
07/07/1998US5777160 1, 4, 4-(trisubstituted) cyclohex-1-ene dimers and related compounds
07/07/1998US5776974 Immunosuppressant compounds
07/07/1998US5776966 Selective cell inactivation in blood
07/07/1998US5776943 Rapamycin metabolites
07/07/1998US5776940 Compounds for treatment of septic shock, antiinflammatory and antiallergens
07/07/1998US5776933 Method of inhibiting protease
07/07/1998US5776932 1,3,5-tribsubstituted indazole derivatives, processes for preparing, and for pharmacological treatment therewith
07/07/1998US5776910 Dna molecule codes and fc receptors
07/07/1998US5776761 Nucleic acids encoding allergenic proteins from ragweed
07/07/1998US5776758 Cysteine protease derived from parasitic helminths
07/07/1998US5776750 Amino acid sequences and polypeptides for hybridizing and genes
07/07/1998US5776468 Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A
07/02/1998WO1998028426A2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
07/02/1998WO1998028425A1 Mammalian cytokine related to il10
07/02/1998WO1998028424A2 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
07/02/1998WO1998028418A1 Tailless nuclear hormone receptor (tlx receptor)
07/02/1998WO1998028330A1 Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
07/02/1998WO1998028301A1 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
07/02/1998WO1998028292A1 Novel piperidine containing compounds
07/02/1998WO1998028281A1 Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
07/02/1998WO1998028276A1 Triarylethanes useful as pde iv inhibitors
07/02/1998WO1998028003A1 Formulations of recombinant papillomavirus vaccines
07/02/1998WO1998027966A2 Encapsulated cells producing antibodies
07/02/1998WO1998014445A3 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
07/02/1998CA2275312A1 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
07/02/1998CA2275138A1 Mammalian cytokine related to il10
07/02/1998CA2246787A1 Novel compounds
07/01/1998EP0850924A1 Aromatic diselenides and selenosulphides for use as antioxidant agents
07/01/1998EP0850909A1 Stilbene compounds with adamantyl group, compositions containing the same and uses
07/01/1998EP0850240A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
07/01/1998EP0850236A1 Piperazino derivatives as neurokinin antagonists
07/01/1998EP0850215A1 N-(aroyl)glycine hydroxamic acid derivatives and related compounds
07/01/1998EP0850071A1 Gene therapy for effector cell regulation
07/01/1998EP0850070A2 Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response
07/01/1998EP0695308B1 Novel heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same
1 ... 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 ... 1172